Browse Category

Industry News News 9 October 2025 - 31 October 2025

Former Deloitte Chair Joins Conduent Board – Can His Expertise Turn the Tide?

Former Deloitte Chair Joins Conduent Board – Can His Expertise Turn the Tide?

A Big-Name Appointment: Who Is Michael J. Fucci? Conduent’s decision to add Michael J. Fucci to its board brings a high-profile leader into the fold. Fucci is best known for his tenure as Chairman of Deloitte US from 2015 to 2019, where he provided governance and strategic oversight at one of the “Big Four” consulting firms businesswire.com. During his 40-year career at Deloitte (which he joined in 1981), Fucci played a pivotal role in expanding the firm’s human capital consulting business and later served as Deloitte’s Chief Operating Officer businesswire.com. He retired from Deloitte in 2020, capping a career that
Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Novo Nordisk hijacks Pfizer’s Metsera deal with a $9B bid – obesity-drug war heats up

Novo’s counter-offer details Novo Nordisk’s proposal is unsolicited, meaning Metsera’s board and shareholders will now review it against Pfizer’s agreement. Novo emphasizes that Metsera’s experimental therapies would be “complementary” to its own obesity portfolio reuters.com. According to MarketScreener (Dow Jones Newswires), the bid is $56.50 in cash per Metsera share plus $21.25 in milestone CVRs marketscreener.com. By contrast, Pfizer’s September deal was $4.9B upfront (about $28.50/share) plus CVRs, for up to ~$7.3B ts2.tech reuters.com. Novo’s offer thus values the company at roughly $6.5B upfront, sweetened to ~$9B with earnouts. Novo’s CEO Maziar “Mike” Doustdar hailed the move as proof of
India Shakes Up Aviation: HAL Partners with Russia to Manufacture SJ-100 Jets – Boeing & Airbus Beware

India Shakes Up Aviation: HAL Partners with Russia to Manufacture SJ-100 Jets – Boeing & Airbus Beware

Sources: HAL and government statements and press reports moneycontrol.com timesofindia.indiatimes.com flightglobal.com flightglobal.com; industry analysis and market data reuters.com flightglobal.com in.investing.com; stock market data (Moneycontrol) moneycontrol.com reuters.com; TS2 technews analysis ts2.tech ts2.tech. All facts verified up to Oct 28, 2025.
Gundremmingen Cooling Towers Implode – Who Wins & Loses on Energy Stocks?

Gundremmingen Cooling Towers Implode – Who Wins & Loses on Energy Stocks?

Key Facts: On Oct 25, 2025 at 12:00, Germany will detonate the two 160 m cooling towers of the former Gundremmingen nuclear plant in Bavaria sueddeutsche.de. In a matter of seconds the 56,000 tons of reinforced concrete will collapse and be recycled as aggregate sueddeutsche.de. A large exclusion zone surrounds the site (violators face up to €3,000 fines) sueddeutsche.de. About 10,000 spectators are expected (no official festival will be held) merkur.de merkur.de. Engineers have cut structural slots and will trigger water-jet fountains to force the towers to collapse inward and bind dust merkur.de. Gundremmingen was one of Germany’s first atomic power
Boeing Back in the Sky: FAA Approval and Jet Orders Lift BA Stock – What Analysts Say

Boeing Back in the Sky: FAA Approval and Jet Orders Lift BA Stock – What Analysts Say

Near-term forecasts: Analysts are watching Boeing’s progress closely. Many note that Boeing still has to clear remaining certification hurdles and manage its supply chain. Aerospace strategist Tony Bancroft (Gabelli Funds) calls Boeing a “long-term winner,” noting its robust backlog and improving controls qz.com. Bernstein’s Harned expects Boeing to meet its year-end production goals now that rework is done investing.com. S&P global analyst Ben Tsocanos (cited in 2024) said new liquidity measures were “prudent” given Boeing’s credit needs. Overall, market-watchers see Boeing’s stock as having room to run if deliveries and cash flow keep improving – but the company’s own caution
20 October 2025
Novo Nordisk’s $5.2 Billion Bet to Reverse Fatty Liver Disease – Game-Changer or Big Gamble?

Novo Nordisk’s Weight-Loss Crown at Risk? NVO Stock Slumps Amid Surprise Deals – What’s Next

NVO Stock Slides as Weight-Loss Hype Cools Novo Nordisk’s stock has been on a wild ride. After becoming Europe’s most valuable company in 2022–2023 on the back of its smash-hit obesity drug Wegovy, the Danish pharma giant has seen its fortunes reverse sharply in 2025. As of October 17, NVO shares trade in the mid-$50s – down nearly 50% from January levels reuters.com reuters.com and miles below the late-2024 peak (when Novo’s market cap neared $650 B) reuters.com reuters.com. What happened? In short, the once-unbounded GLP-1 weight-loss boom has hit reality. Several factors have converged to deflate Novo’s valuation. Competition has
NuScale Stock Skyrockets on Historic SMR Deal – Can GE Vernova Catch Up in the Nuclear Boom?

NuScale Stock Skyrockets on Historic SMR Deal – Can GE Vernova Catch Up in the Nuclear Boom?

NuScale’s Historic SMR Deal Sparks a Nuclear Stock Rally NuScale Power’s stock is on fire after the company secured a massive 6 gigawatt SMR deployment program with the Tennessee Valley Authority (TVA) – “the largest SMR deployment in U.S. history,” according to NuScale ts2.tech. The deal, executed via NuScale’s ENTRA1 Energy venture, will see up to six 77 MWe modular reactors installed in TVA’s service area, enough to power ~4.5 million homes and dozens of data centers ts2.tech. Investors cheered the news: on October 13, SMR shares spiked ~14% intraday, and by mid-week the stock was trading around $55 – roughly 20% higher
Microvast Stock Skyrockets 19% on $125M Equity Raise & Battery Breakthroughs

Microvast (MVST) Stock Hits New High on Battery Breakthroughs and $125 M Funding – What’s Next?

Stock Performance: Rally to Multi-Year Highs Microvast’s stock price has seen a spectacular run-up in October, far outpacing the broader market as investors pile in on growth hopes. Volume spiked to nearly 20 million shares on Oct. 15, about three times the monthly average, reflecting surging interest. Microvast’s shares have been on a tear, skyrocketing in mid-October to levels not seen in years. The stock broke out of its recent trading range last week – it was around $4.33 on Oct. 10, then $5.25 by Oct. 14 ts2.tech – before exploding ~19% higher on Oct. 15 to close around $6.25
NuScale’s Stock Skyrockets on 6GW SMR Deal – Is GE Vernova Missing Out?

NuScale’s Stock Skyrockets on 6GW SMR Deal – Is GE Vernova Missing Out?

Analysts Weigh In Analysts note that SMR’s recent rally reflects both real progress and speculative fervor. On one hand, NuScale’s NRC approvals and partnerships set it up as an industry leader finviz.com ts2.tech. In early October, NuScale shares even spiked +5% when Italy’s government moved to reintroduce nuclear power with “modular” reactors nasdaq.com nasdaq.com. On the other hand, NuScale still loses money (burning ~$95M cash per quarter as of mid-2025) and faces stiff competition nasdaq.com finviz.com. The Zacks report notes NuScale has underperformed peers recently (SMR +12.7% in 3 months vs. GE Vernova +17.6%, NanoNuclear +35%) finviz.com. It warns that
Battery Boom: American Battery Technology Surges on Recycling Deal & $900M Lithium Loan

Battery Boom: American Battery Technology Surges on Recycling Deal & $900M Lithium Loan

Company Profile & Strategy American Battery Technology Company (NASDAQ: ABAT, ticker often ABAT) is a Reno, Nevada-based “critical battery materials” company globenewswire.com globenewswire.com. It pioneers a full lifecycle approach to lithium-ion batteries: mining domestic mineral deposits (like Tonopah Flats) and recycling spent batteries for lithium, cobalt, nickel, etc. ABTC’s mission statement emphasizes innovation in “first-of-kind technologies” to produce and recycle battery metals domestically, reducing US reliance on foreign sources globenewswire.com. Key to this is ABTC’s proprietary processing: for example its Tonopah Flats project will use a selective leach extraction (SLE) method to turn claystone directly into battery-grade lithium hydroxide, which
13 October 2025
Iron-Flow Battery Revolution: ESS Tech’s Stock Soars on Major SRP Deal – Analysts Weigh In

Iron-Flow Battery Revolution: ESS Tech’s Stock Soars on Major SRP Deal – Analysts Weigh In

Key Facts at a Glance: – ESS Tech, Inc. (NYSE: GWH) is a long-duration energy storage company focused on iron-based flow batteries investors.essinc.com. The firm (founded 2011, ~240 employees) designs, builds and deploys large-scale “iron flow” battery systems for utilities and commercial customers essinc.com marketscreener.com. Its products (Energy Warehouse, Energy Center, and the new Energy Base platform) use cheap, earth-abundant iron, salt and water in the electrolyte investors.essinc.com marketscreener.com. ESS touts that its batteries are “safe and sustainable with no risk of thermal runaway” and have a 25+ year lifespan essinc.com. As of Oct 9, 2025 close, GWH traded around
1 2 3 4 7
Go toTop